KAREN TRACY: Open Payments
NPI 1346252293 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 47 payments from 22 companies in 2025. Trend: 2023 $535 · 2024 $1,201 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 7 | $197 |
| AstraZeneca Pharmaceuticals LP | 5 | $135 |
| Exact Sciences Corporation | 5 | $96 |
| Dexcom, Inc. | 4 | $82 |
| ABBVIE INC. | 4 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Seqirus USA Inc | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: NUZYRA, BREZTRI, Dexcom G6 Transmitter, Cologuard Collection Kit, ZENPEP, REXULTI, GVOKE HYPOPEN, FARXIGA.
Industry payments across MO — which companies pay providers there.
